119 related articles for article (PubMed ID: 3034423)
21. [Mixed mesodermal tumor of the uterus].
Marczewska J
Patol Pol; 1989; 40(2):253-6. PubMed ID: 2561609
[No Abstract] [Full Text] [Related]
22. Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
Miller DS; Blessing JA; Schilder J; Munkarah A; Lee YC
Gynecol Oncol; 2005 Aug; 98(2):217-21. PubMed ID: 15975641
[TBL] [Abstract][Full Text] [Related]
23. [Mixed mesodermal tumor of the uterus].
Sanbe T; Miyajima Y; Nakayama M; Suzuki K; Tokunaga T
Sanfujinka No Jissai; 1968 Oct; 17(10):867-77. PubMed ID: 4303643
[No Abstract] [Full Text] [Related]
24. [Malignant mixed mesodermal tumors of the uterus: a clinicopathologic report of 12 cases].
Zhao M
Zhonghua Fu Chan Ke Za Zhi; 1982 Oct; 17(4):208-10. PubMed ID: 6295716
[No Abstract] [Full Text] [Related]
25. [Combination chemotherapy of uterine sarcomas].
Bai P; Zhang W; Sun J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):80-2. PubMed ID: 11776610
[TBL] [Abstract][Full Text] [Related]
26. [Carcinosarcoma and mixed mesodermal tumors of the uterus: a clinical and pathologic study of 10 cases (author's transl)].
Genton C; Schreiner WE
Schweiz Rundsch Med Prax; 1977 Feb; 66(5):134-9. PubMed ID: 189300
[No Abstract] [Full Text] [Related]
27. [Mixed mesodermal tumor of the uterus (Müller's duct tumors)].
Blessing MH; Fasshauer K
Geburtshilfe Frauenheilkd; 1970 Feb; 30(2):153-8. PubMed ID: 4314625
[No Abstract] [Full Text] [Related]
28. Mesodermal mixed tumors of the uterine corpus.
Mortel R; Koss LG; Lewis JL; D'Urso JR
Obstet Gynecol; 1974 Feb; 43(2):248-52. PubMed ID: 4359077
[No Abstract] [Full Text] [Related]
29. Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
Poplin EA; Liu PY; Delmore JE; Wilczynski S; Moore DF; Potkul RK; Fine BA; Hannigan EV; Alberts DS
Gynecol Oncol; 1999 Sep; 74(3):432-5. PubMed ID: 10479505
[TBL] [Abstract][Full Text] [Related]
30. Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Slavik M; Arsenau JC; Blessing J; Lewis GC
Am J Clin Oncol; 1982 Oct; 5(5):483-6. PubMed ID: 6897490
[No Abstract] [Full Text] [Related]
31. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD
Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836
[No Abstract] [Full Text] [Related]
32. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
Conroy JF; Blessing JA; Kessinger A; Homesley HD
Cancer Treat Rep; 1984 Feb; 68(2):439-40. PubMed ID: 6697335
[No Abstract] [Full Text] [Related]
34. [Disontogenetic neoplasms in the female genital tract. Formal and onto-histogenetic differences between mixed mesodermal tumor, müllerian tumor and stromatic sarcoma of the uterus].
Tomasino RM; Perino A; Anastasi M
Arch De Vecchi Anat Patol; 1973 Dec; 59(2):293-318. PubMed ID: 4374141
[No Abstract] [Full Text] [Related]
35. A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
Resnik E; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1995 Mar; 56(3):370-5. PubMed ID: 7705670
[TBL] [Abstract][Full Text] [Related]
36. Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group.
Smith HO; Blessing JA; Vaccarello L
Gynecol Oncol; 2002 Jan; 84(1):140-4. PubMed ID: 11748990
[TBL] [Abstract][Full Text] [Related]
37. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
[TBL] [Abstract][Full Text] [Related]
38. [Rare tumors of the female genital tract: mullerian tumor of the uterus. Definition of the concept of mullerian tumor and its distinction from mesodermal mixed tumors].
Tomasino RM; Romano FM
Arch De Vecchi Anat Patol; 1968 Mar; 51(1):211-26. PubMed ID: 4311263
[No Abstract] [Full Text] [Related]
39. Cytologic features of a mixed mesodermal tumor of the uterus demonstrated by cells obtained with the mi-mark endometrial sampler.
Mitchard PJ; Swingler GR; Cave DG
Acta Cytol; 1980; 24(4):363-5. PubMed ID: 6251684
[TBL] [Abstract][Full Text] [Related]
40. Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; DiSaia PJ; Ehrlich CE
Cancer Treat Rep; 1987 Feb; 71(2):217-8. PubMed ID: 3802120
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
